|Articles|November 1, 2018
- Pharmaceutical Executive-11-01-2018
- Volume 38
- Issue 11
Pharmaceutical Executive, November 2018 Issue (PDF)
Click the title above to open the Pharmaceutical November 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Pharm Exec's 2019 Pipeline Reportover 7 years ago
High-Risk Marketing Violations Draw Scrutinyover 7 years ago
Biopharma Business Checkover 7 years ago
Patent Protection for Cannabis?over 7 years ago
Steadying the Path of Good Scienceover 7 years ago
Southeast Biotech: Rising Tall in the Valleyalmost 8 years ago
Fighting for a Streamlined European HTA Schemealmost 8 years ago
Stunted Innovation in Drug Development?almost 8 years ago
Country Report: AlgeriaAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Significance of FDA’s First Warning Letter for Inappropriate Use of AI
2
Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion
3
Generating Commercial Evidence from Agentic Field and Brand Engagement to Accelerate Launch Performance
4
M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo
5